Edesa Biotech Liabilities 2024

Edesa Biotech Aktienanalyse

What does Edesa Biotech do?

Edesa Biotech Inc is a Canadian-based company that focuses on the development of novel therapeutic drugs. The company was founded in 2015 and has since achieved numerous significant advancements and successes. Edesa Biotech ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Liabilities Details

Assessing Edesa Biotech's Liabilities

Edesa Biotech's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating Edesa Biotech's financial stability, operational efficiency, and long-term viability.

Year-to-Year Comparison

By comparing Edesa Biotech's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.

Impact on Investments

Edesa Biotech's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.

Interpreting Liability Fluctuations

Shifts in Edesa Biotech’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.

Frequently Asked Questions about Edesa Biotech Stock

What is the level of liabilities of Edesa Biotech this year?

Edesa Biotech has a debt balance of 1.84 M USD this year.

What were the liabilities of Edesa Biotech compared to the previous year?

The liabilities of Edesa Biotech have increased by -15.52% dropped compared to the previous year.

What are the consequences of high debt for investors of Edesa Biotech?

High liabilities can pose a risk for investors of Edesa Biotech, as they can weaken the company's financial position and impair its ability to meet its obligations.

What consequences do low liabilities have for investors in Edesa Biotech?

Low liabilities mean that Edesa Biotech has a strong financial position and is able to meet its obligations without overburdening its finances.

How does an increase in liabilities of Edesa Biotech affect the company?

An increase in liabilities of Edesa Biotech can lead to the company having more obligations and potentially find it more difficult to meet its financial commitments.

How does a reduction in the liabilities of Edesa Biotech affect the company?

A decrease in the liabilities of Edesa Biotech can lead to the company having fewer obligations and a stronger financial position, which can make it easier for the company to fulfill its financial commitments.

What are some factors that influence the liabilities of Edesa Biotech?

Some factors that can influence the liabilities of Edesa Biotech include investments, acquisitions, operating costs, and sales development.

Why is the level of liabilities of Edesa Biotech so important for investors?

The liabilities of Edesa Biotech are important for investors as they serve as an indicator of the company's financial stability and provide investors with information on how the company meets its financial obligations.

What strategic measures can Edesa Biotech take to modify the liabilities?

To change its liabilities, Edesa Biotech can take measures such as cost savings, increasing revenue, selling assets, raising investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to choose the best strategic actions.

How much dividend does Edesa Biotech pay?

Over the past 12 months, Edesa Biotech paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Edesa Biotech is expected to pay a dividend of 0 USD.

What is the dividend yield of Edesa Biotech?

The current dividend yield of Edesa Biotech is .

When does Edesa Biotech pay dividends?

Edesa Biotech pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Edesa Biotech?

Edesa Biotech paid dividends every year for the past 0 years.

What is the dividend of Edesa Biotech?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Edesa Biotech located?

Edesa Biotech is assigned to the 'Health' sector.

Wann musste ich die Aktien von Edesa Biotech kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Edesa Biotech from 5/15/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 5/15/2024.

When did Edesa Biotech pay the last dividend?

The last dividend was paid out on 5/15/2024.

What was the dividend of Edesa Biotech in the year 2023?

In the year 2023, Edesa Biotech distributed 0 USD as dividends.

In which currency does Edesa Biotech pay out the dividend?

The dividends of Edesa Biotech are distributed in USD.